SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

ZIM Laboratories invests Rs 68.25 lakh in ZIMTAS

02 Jul 2024 Evaluate

ZIM Laboratories has invested Rs 68.25 lakh which is AUD 1,23,525 (Australian Dollars) in the equity shares of ZIMTAS, out of the approved investment amount of up to Rs 2 crore. Post investment, the company holds 99.93% of the total share capital of ZIMTAS. 

Earlier, the company’s board had approved investment of upto Rs 2 crore in equity shares of ZIMTAS, subsidiary of the company. The Investment is with an objective of Business Development in Australian and New Zealand markets. 

ZIM Laboratories manufactures, formulates, and distributes drug delivery systems to develops generic pharmaceutical products.


Zim Laboratories Share Price

79.72 3.72 (4.89%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×